Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Which assessment tools best distinguish between mild cognitive impairment and dementia? Lessons from a Slovak memory clinic cohort.

BMC geriatrics·2026

Same author

Youth Soccer Participation and Brain Health Outcomes in Adolescent Athletes.

JAMA network open·2026

Same author

Anxiety-like behaviour in mice after mild repetitive head impacts during the subacute phase.

Frontiers in behavioral neuroscience·2026

Same author

Targeting low-grade inflammation in multiple sclerosis through the Wim Hof method or lifestyle intervention: a pilot comparative study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Same author

When Proteins Go MAD-Misfolded, Amplified, Detected: Advances in α-Synuclein Pathophysiology and RT-QuIC Detection.

Molecular neurobiology·2026

Same author

Changes in peripheral blood and cognitive performance after nonconcussive head impacts in elite female soccer players.

Communications medicine·2025

Same journal

Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adults.

Neurobiology of aging·2026

Same journal

Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease.

Neurobiology of aging·2026

Same journal

Brain structure in the cingulate cortex and locus coeruleus in late life is associated with engagement in complex mental activities across the life span.

Neurobiology of aging·2026

Same journal

Age-related differences in motor learning, sensorimotor neurochemistry, and cortical reactivity co-occur but are dissociated.

Neurobiology of aging·2026

Same journal

How cognition and hearing-related measures covary with hippocampal subfield features from structural MRI in younger and older adults.

Neurobiology of aging·2026

Same journal

Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals.

Neurobiology of aging·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Generation of Transgenic Rats using a Lentiviral Vector Approach

Generation of Transgenic Rats using a Lentiviral Vector Approach

Published on: May 17, 2020

First transgenic rat model developing progressive cortical neurofibrillary tangles.

Peter Filipcik¹, Norbert Zilka, Ondrej Bugos

¹Institute of Neuroimmunology, Slovak Academy of Sciences, Centre of Excellence for Alzheimer's Disease and Related Disorders, Bratislava, Slovak Republic.

Neurobiology of Aging

|January 4, 2011

Summary

This summary is machine-generated.

A new transgenic rat model exhibits Alzheimer's-like neurofibrillary degeneration, developing tau tangles in the brain. This model is valuable for testing new Alzheimer's disease (AD) drugs.

More Related Videos

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Generation of Transgenic Rats using a Lentiviral Vector Approach

Generation of Transgenic Rats using a Lentiviral Vector Approach

Published on: May 17, 2020

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Area of Science:

Neuroscience
Pathology
Genetics

Background:

Neurofibrillary degeneration, driven by misfolded tau protein, is a hallmark of Alzheimer's disease (AD).
Developing accurate models is crucial for understanding AD pathogenesis and for preclinical drug development.

Purpose of the Study:

To introduce and characterize a novel transgenic rat model that recapitulates key features of human tauopathy.
To assess the utility of this model for studying Alzheimer's-type neurofibrillary degeneration.

Main Methods:

Generation of transgenic rats expressing a specific human truncated tau fragment (3R tau151-391).
Histological and biochemical analyses of brain tissue to identify neurofibrillary tangles (NFTs) and tau pathology.
Assessment of neuronal loss in cortical and hippocampal regions.

Main Results:

Transgenic rats developed progressive, age-dependent neurofibrillary degeneration in cortical areas.
NFTs exhibited histological characteristics of human AD pathology (argyrophilia, Congo red birefringence, Thioflavin S reactivity).
Pathological tau was confirmed using specific antibodies, and insoluble tau complexes were observed, yet neuronal loss was absent.

Conclusions:

The novel transgenic rat model successfully replicates key aspects of human tauopathy and Alzheimer's-like neurofibrillary degeneration.
This model provides a valuable platform for preclinical drug discovery targeting tauopathies.
The absence of neuronal loss in this model highlights its specific utility for studying early-stage tau pathology and therapeutic interventions aimed at preventing neurodegeneration.